Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.

[1]  T. Giordano,et al.  B-RafV600E and thrombospondin-1 promote thyroid cancer progression , 2010, Proceedings of the National Academy of Sciences.

[2]  B. Bochner,et al.  The effect of age and gender on bladder cancer: a critical review of the literature , 2010, BJU international.

[3]  L. Yıldız,et al.  Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. , 2009, Pathology, research and practice.

[4]  J. Lawler,et al.  The effect of thrombospondin-1 on breast cancer metastasis , 2009, Breast Cancer Research and Treatment.

[5]  L. Kiemeney,et al.  Epidemiology and genetic susceptibility to bladder cancer , 2008, BJU international.

[6]  N. Malats,et al.  Epidemiology of urinary bladder cancer: from tumor development to patient’s death , 2007, World Journal of Urology.

[7]  Flora Peyvandi,et al.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. , 2006, Blood.

[8]  R. Khosravi‐Far,et al.  Regulation of tumor angiogenesis by thrombospondin-1. , 2006, Biochimica et biophysica acta.

[9]  D. Mosher,et al.  A Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Artery Disease Alters Ca2+ Binding* , 2004, Journal of Biological Chemistry.

[10]  L. Martiny,et al.  Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. , 2004, Critical reviews in oncology/hematology.

[11]  K. O'Byrne,et al.  Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer. , 2002, European urology.

[12]  J. Lawler,et al.  Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth , 2002, Journal of cellular and molecular medicine.

[13]  E. Rofstad,et al.  Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts. , 2001, The Journal of investigative dermatology.

[14]  J. Lawler,et al.  The cell biology of thrombospondin-1. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[15]  C. Kwak,et al.  The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts , 2000, Cancer Gene Therapy.

[16]  E Dorant,et al.  The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.

[17]  J. Fraumeni,et al.  Cancer incidence trends in urban Shanghai, 1972–1994: An update , 1999, International journal of cancer.

[18]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[19]  N. Fusenig,et al.  Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Campbell,et al.  Molecular mediators of angiogenesis in bladder cancer. , 1998, Cancer research.

[21]  S. Groshen,et al.  Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. , 1997, Journal of the National Cancer Institute.

[22]  G. Tuszynski,et al.  Expression of Thrombospondin-1 in Cancer: A Role in Tumor Progression , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  D. Walz.  Thrombospondin as a mediator of cancer cell adhesion in metastasis , 1992, Cancer and Metastasis Reviews.

[24]  S. Wong,et al.  Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. , 1992, The American journal of pathology.

[25]  M. Iruela-Arispe,et al.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Spencer,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[27]  Carol D. Laherty,et al.  Characterization of the promoter region of the human thrombospondin gene. DNA sequences within the first intron increase transcription. , 1989, The Journal of biological chemistry.

[28]  G. Tuszynski,et al.  Thrombospondin, a potentiator of tumor cell metastasis. , 1987, Cancer research.

[29]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[30]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[31]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[32]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[33]  M. Zeegers,et al.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review , 2003, World Journal of Urology.